CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit.

Text measurement CureVac’s vaccine was 47% efficient at stopping Covid-19 signs in a trial of 40,000 volunteers. JEROEN JUMELET/ANP/AFP through

Read more